Publications by authors named "Nati Lerman"

Claim this Profile
C
Corrigendum to "PD-L1 testing patterns in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) in the U.S." [Oral Oncol. 161 (2025) 107146].
Glenn J Hanna, Dandan Zheng, Wei Gao, Gleicy M Hair, Lei Ai, Nati Lerman

Oral Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment patterns and clinical outcomes among elderly patients with locoregionally advanced head and neck squamous cell carcinoma in the United States.
Dandan Zheng, Su Zhang, Behzad Bidadi, Nati Lerman, Yan Song

Front Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study.
Makoto Tahara, Richard Greil, Danny Rischin, Kevin J Harrington, Barbara Burtness, Nati Lerman

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 testing patterns in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) in the U.S.
Glenn J Hanna, Dandan Zheng, Wei Gao, Gleicy M Hair, Lei Ai, Nati Lerman

Oral Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line pembrolizumab with or without chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up of the Japanese population of KEYNOTE‑048.
Nobuhiko Oridate, Shunji Takahashi, Kaoru Tanaka, Yasushi Shimizu, Yasushi Fujimoto, Nati Lerman

Int J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world use of first-line pembrolizumab + platinum + taxane combination regimens in recurrent / metastatic head and neck squamous cell carcinoma.
Christopher M Black, Dandan Zheng, Gleicy M Hair, Lei Ai, Liya Wang, Nati Lerman

Front Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib with or without bevacizumab or bevacizumab and 5-fluorouracil in advanced colorectal cancer: Phase III LYNK-003.
Tae Won Kim, Julien Taieb, Ellen B Gurary, Nati Lerman, Karen Cui

Future Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High grade sarcoma, with predominant neuroectodermal and minor embryonal rhabdomyosarcomatous tumor of the uterus: A case report.
Leona Chang, Miriam Enriquez, Nati Lerman, Robin Wilson-Smith

Gynecol Oncol Rep· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative Radiosurgery for Soft Tissue Sarcoma.
Gregory J Kubicek, Tamara LaCouture, Maureen Kaden, Tae Won Kim, Nati Lerman

Am J Clin Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiologic images of an aggressive implant-associated fibromatosis of the breast and chest wall: case report and review of the literature.
Lourdes Alanis, Robyn Roth, Nati Lerman, Julieta E Barroeta, Pauline Germaine

Radiol Case Rep· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Radiosurgery for Poor Performance Status Patients.
Gregory J Kubicek, Alan Turtz, Jinyu Xue, Ashish Patel, Gregory Richards, Nati Lerman

Int J Radiat Oncol Biol Phys· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis